Pharmaceuticals, Biotechnology and Life Sciences
A Plan for Compliance has been UndertakenOCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”…
Participants can register here for the virtual event airing 9:00am ET / 3:00pm CET PARIS and CAMBRIDGE, Mass., Dec. 17,…
The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to…
TARRYTOWN, N.Y., Dec. 17, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 43rd…
Up to $200 million financing, includes $50 million upfrontREDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc.…
WEST LAFAYETTE, Ind., Dec. 17, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization…
Preclinical studies with ACCG-2671 demonstrate potent target engagement, robust weight loss, favorable safety profile and PK properties supportive of once-daily…
Company to host conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT on Wednesday, December 18, 2024BURLINGAME,…
Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the…
Reference is made to the stock exchange announcement by Ultimovacs ASA (“Ultimovacs” or the “Company”) on 17 December 2024 regarding…